URL details: allaboutreblozyl.com
URL title:
Reblozyl® (luspatercept-aamt) Efficacy | MDS-RS | MEDALIST Trial Design | HCP
URL description:
Reblozyl® was studied in the multicenter, randomized, double-blind, placebo-controlled, phase 3 MEDALIST trial. See safety information, including thrombosis, hypertension, & embryo-fetal toxicity.
URL last crawled:
2022-07-21
URL speed:
1.330 MB/s,
downloaded in 0.090 seconds
We found no external links pointing to this url.